575 related articles for article (PubMed ID: 18375152)
1. Management of hypertension in peripheral arterial disease: does the choice of drugs matter?
Singer DR; Kite A
Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):701-8. PubMed ID: 18375152
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
3. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
4. Adults with diabetes - pharmacological management of hypertension.
Jackowski L; Crockett J; Rowett D
Aust Fam Physician; 2008 Jun; 37(6):419-21. PubMed ID: 18523694
[TBL] [Abstract][Full Text] [Related]
5. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction.
Mancia G
Acta Diabetol; 2005 Apr; 42 Suppl 1():S17-25. PubMed ID: 15868115
[TBL] [Abstract][Full Text] [Related]
6. Management of cardiovascular risk with RAS inhibitor/CCB combination therapy.
Dahlöf B
J Hum Hypertens; 2009 Feb; 23(2):77-85. PubMed ID: 18685606
[TBL] [Abstract][Full Text] [Related]
7. The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.
McAlister FA; Levine M; Zarnke KB; Campbell N; Lewanczuk R; Leenen F; Rabkin S; Wright JM; Stone J; Feldman RD; Lebel M; Honos G; Fodor G; Burgess E; Tobe S; Hamet P; Herman R; Irvine J; Culleton B; Petrella R; Touyz R;
Can J Cardiol; 2001 May; 17(5):543-59. PubMed ID: 11381277
[TBL] [Abstract][Full Text] [Related]
8. Choice of antihypertensive drug in the diabetic patient.
Ong HT; Cheah JS
MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452
[TBL] [Abstract][Full Text] [Related]
9. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
Guo QH; Pan CY; Qi WH; Lin SY;
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
[TBL] [Abstract][Full Text] [Related]
10. [Treatment for hypertension with diabetes mellitus].
Shimamoto K; Miura T
Nihon Rinsho; 2006 Nov; 64(11):2097-101. PubMed ID: 17087302
[TBL] [Abstract][Full Text] [Related]
11. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
12. [Management of hypertension in CKD patients].
Kusaba T; Kimura K
Nihon Rinsho; 2008 Sep; 66(9):1747-52. PubMed ID: 18788405
[TBL] [Abstract][Full Text] [Related]
13. [Success of blood pressure reduction in diabetic patients].
Schernthaner G
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S247-51. PubMed ID: 17139580
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting the renin-angiotensin system: why and in which patients.
Berra K; Miller NH
J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.
Blinc A; Poredos P
Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482
[TBL] [Abstract][Full Text] [Related]
16. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected.
Paraskevas KI; Giannoukas AD; Mikhailidis DP
Ann Vasc Surg; 2009; 23(5):690-9. PubMed ID: 19747617
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure-lowering drugs: essential therapy for some patients with normal blood pressure.
Fuchs FD
Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):771-5. PubMed ID: 15350178
[TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome in hypertension: European society of hypertension position statement.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular protection paradigms: is change on the horizon?
Papademetriou V
Rev Cardiovasc Med; 2007; 8(4):200-13. PubMed ID: 18192943
[TBL] [Abstract][Full Text] [Related]
20. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
Palmer BF
Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
